In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI-Designated Cancer Centers

Page Options

  • Print This Page
  • Email This Document

Popular Resources

Herbert Irving Comprehensive Cancer Center

Stephen G. Emerson, M.D., Ph.D.
Director

1130 St. Nicholas Avenue, Room 508
New York, New York 10032
Main: (212) 305-2500
24 Hour Hotline: 1-877-697-9355

Visit Website

Herbert Irving Comprehensive Cancer Center
Columbia University
New York, New York

Founded in 1911 as the Institute for Cancer Research, the Cancer Center at Columbia University became an NCI-designated cancer center in 1972 and achieved comprehensive status in 1979. Known as the Herbert Irving Comprehensive Cancer Center (HICCC), it is the University’s organizational component for the conduct of basic, clinical, and population-based cancer research and patient care.

The Center’s mission is to understand the biology of cancer and apply that knowledge to the design of cancer therapies and prevention strategies that reduce its incidence and progression and improve the quality of the lives of those affected by cancer. HICCC has over 200 members drawn from six schools at Columbia.

Research at HICCC is organized into eight research programs within three divisions. The Basic Science Division includes programs in cancer genetics and epigenetics, and cancer signaling networks. Programs in the Disease-Specific Division focus on breast cancer, lymphoid development and malignancy, prostate cancer, and neuro-oncology. The Population Science Division’s programs cover cancer epidemiology as well as prevention, control, and disparities. These programs focus on different aspects of cancer from its molecular and cellular mechanisms through its unique behavior in different tissues to statistical aspects of its occurrence and treatment in large populations. The members of each program share a commitment to reduce cancer incidence and tumor progression and to improve the quality of life of those affected by cancer.

The Center offers training programs in affiliation with the University in the areas of basic laboratory research, epidemiology and public health, and clinical science, with a special focus on cancer biology, environmental health/epidemiology, and adult and pediatric hematology/oncology.

Cancer-related patient services are provided at New York Presbyterian Hospital. This partnership allows the researchers and clinicians at HICCC to bring together the best approaches for prevention, diagnosis, and treatment of all types of cancer. HICCC also offers participation in clinical trials.

HICCC is located in the Washington Heights neighborhood, one of the most ethnically and racially diverse populations in New York City. The Center has created a range of patient care and clinical research programs to bring its services to every group in the neighborhood. To that end, HICCC has developed three specific programs: the Research Recruitment and Minority Outreach Program to bring underrepresented people into clinical trials; the Columbia University Cancer Screening Program; and the Women at Risk Program to provide education and services on breast cancer to a population with above average risk of the disease.

* This profile was provided by the Herbert Irving Comprehensive Cancer Center.